Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses

PLoS One. 2014 Sep 30;9(9):e108808. doi: 10.1371/journal.pone.0108808. eCollection 2014.

Abstract

CpG-oligodeoxynucleotides (CpG-ODN) are potent immune stimuli being developed for use as adjuvants in different species. Toll-like receptor 9 (TLR9) is the cellular receptor for CpG-ODN in mammalian cells. The CpG-ODN with 18-24 deoxynucleotides that are in current use for human and mouse cells, however, have low activity with rabbit TLR9. Using a cell-based activation assay, we developed a type of CpG-ODN containing a GACGTT or AACGTT motif in 12 phosphorothioate-modified deoxynucleotides with potent stimulatory activity for rabbit TLR9. The developed CpG-ODN have higher activities than other developed CpG-ODN in eliciting antigen-nonspecific immune responses in rabbit splenocytes. When mixed with an NJ85 peptide derived from rabbit hemorrhagic disease virus, they had potent activities to boost an antigen-specific T cell activation and antibody production in rabbits. Compared to Freund's adjuvant, the developed CpG-ODN are capable of boosting a potent and less toxic antibody response. The results of this study suggest that both the choice of CpG-motif and its length are important factors for CpG-ODN to effectively activate rabbit TLR9 mediated immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / chemistry
  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Antibody Formation / drug effects
  • Base Sequence
  • Cytokines / metabolism
  • HEK293 Cells
  • Hemorrhagic Disease Virus, Rabbit / metabolism
  • Humans
  • Immunoglobulin M / metabolism
  • Lymphocyte Activation / drug effects*
  • Oligodeoxyribonucleotides / chemistry
  • Oligodeoxyribonucleotides / pharmacology*
  • Peptides / chemistry
  • Peptides / pharmacology
  • Phosphates / chemistry
  • Rabbits
  • Spleen / drug effects
  • Spleen / metabolism
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Toll-Like Receptor 9 / metabolism*

Substances

  • Adjuvants, Immunologic
  • CPG-oligonucleotide
  • Cytokines
  • Immunoglobulin M
  • Oligodeoxyribonucleotides
  • Peptides
  • Phosphates
  • Toll-Like Receptor 9
  • phosphorodithioic acid

Grants and funding

This work was supported in part by grants from the National Health Research Institutes, Taiwan to THC (IM-102-PP-02), and from the National Science Council of Taiwan to THC (NSC102-2320-B-400-009-MY3) and LCH (NSC102-2325-B-002-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.